Publications by authors named "Cliff Ding"

Claim this Profile
F
First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.
Jordan Berlin, Anthony W Tolcher, Cliff Ding, Jennifer G Whisenant, Ivan D Horak

Invest New Drugs· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
Clara Montagut, Guillem Argilés, Fortunato Ciardiello, Thomas T Poulsen, Rodrigo Dienstmann, Cliff Ding

JAMA Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
John P Leonard, Morton Coleman, Jamie Ketas, Michelle Ashe, Jennifer M Fiore, Cliff L Ding

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis